Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP839072.RAmvEv7WuMAi2jZe1mIp2Mh8ODbRxMP7-Llwh2hMcrsPY130_assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839072.RAmvEv7WuMAi2jZe1mIp2Mh8ODbRxMP7-Llwh2hMcrsPY130_provenance.
• NP508152.RAYj6hhiVylLInuDaN-ysCXXhPezX0g6_X9s-CqawlUl0130_assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508152.RAYj6hhiVylLInuDaN-ysCXXhPezX0g6_X9s-CqawlUl0130_provenance.
• NP690328.RAbsHNr5KIsrE3m9LIFUJBtfR9fK49uIkcteuOa9BELSc130_assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690328.RAbsHNr5KIsrE3m9LIFUJBtfR9fK49uIkcteuOa9BELSc130_provenance.
• NP573409.RAEG6wtu-nEKaVisb4SJqAtorWEepp-Sw40eJTfsV1de8130_assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573409.RAEG6wtu-nEKaVisb4SJqAtorWEepp-Sw40eJTfsV1de8130_provenance.
• assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP690327.RAmtaArvUt95SKI12csRcrp2CtPFYjh0dAPHm1_Gh8d_M130_assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690327.RAmtaArvUt95SKI12csRcrp2CtPFYjh0dAPHm1_Gh8d_M130_provenance.
• NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_provenance.
• NP418973.RAJpv08SnAHA_o1iQkgdLd1mve_WCoP-d9MfLcPcNV07o130_assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418973.RAJpv08SnAHA_o1iQkgdLd1mve_WCoP-d9MfLcPcNV07o130_provenance.
• NP690323.RA3c7FtSP8VhLF0WL5jdYUcN9__hffkI_UztwRGGKVYt8130_assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690323.RA3c7FtSP8VhLF0WL5jdYUcN9__hffkI_UztwRGGKVYt8130_provenance.
• NP418972.RA4HAc0rnp53sK9-Z6mNZ_jhLylT8dRss5S8yJ54l1n3c130_assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418972.RA4HAc0rnp53sK9-Z6mNZ_jhLylT8dRss5S8yJ54l1n3c130_provenance.